SpliceBio has closed a Series B financing round, raising $135m for the clinical development of SB-007 for Stargardt disease.

Britons have been urged to check their painkillers after batches of prescription paracetamol were recalled due to contamination fears. The Medicines and Healthcare products Regulatory Agency (MHRA) ...

SIFI, a leading international ophthalmic company, today announced that its shareholders have signed an agreement, subject to conditions precedent, to sell 100% of SIFI shares to Faes Farma, a leading ...

The Scottish Medicines Consortium (SMC) has accepted Outlook Therapeutics’ Lytenava (bevacizumab gamma) for the treatment of ...

A 42-year-old Kentucky woman became pregnant with a miracle Mounjaro baby after years of battling infertility. In July 2022, ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), today announced the Scottish Medicines Consortium (SMC) approval of LYTENAVA™ (bevacizumab gamma) for the treatment of wet age-related macular degeneration ...

The clinical trial at Linkoping University will study Filament's botanical psilocybin drug candidate, PEX010 VANCOUVER, BC, June 11, 2025 /CNW/ - Filament ...

The family of a Newry boy fighting for access to a new "life-changing" medication are now challenging the Belfast Health and ...

The campaign ‘Insurance United Against Dementia’ has appointed Marsh McLennan UK CEO, Chris Lay, as its new chairperson.

A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing ...

How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?